TAM
IMDZ

Tiverton Asset Management’s Immune Design Corp. IMDZ Stock Holding History

Tiverton Asset Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-38,675
Closed -$176K – 437
2018
Q2 		$176K Buy
+38,675
New +$154K 0.01% 330

Other funds holding IMDZ

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tiverton Asset Management's IMDZ Position: Q3 2018 in Review

Tiverton Asset Management sold out of Immune Design Corp. (IMDZ) in Q3 2018, closing a stake of 38,675 shares — an estimated $176K sold.

Tiverton Asset Management first reported a position in IMDZ in Q2 2018 and held it in 1 quarter. The position peaked at $176K in Q2 2018. 71 funds tracked by Wall St. Rank hold IMDZ as of Q3 2018.

  • Tiverton Asset Management reported no remaining Immune Design Corp. position as of Q3 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 38,675 Immune Design Corp. shares in Q3 2018, an estimated $176K.
  • Tiverton Asset Management first reported a position in Immune Design Corp. in Q2 2018 and held it in 1 quarter.
  • Tiverton Asset Management's Immune Design Corp. position peaked at $176K in Q2 2018.
  • 71 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2018.

Based on Tiverton Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.